Healthcare provider profile · identity verified

James Darryl Richards, M.D.

Family Practice · COOKEVILLE, TN · NPI 1831181205

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	664	65
Eliquis	Apixaban	489	55
Trazodone Hcl	Trazodone Hcl	450	65
Furosemide	Furosemide	342	65
Atorvastatin Calcium	Atorvastatin Calcium	304	81
Famotidine	Famotidine	212	53
Sertraline Hcl	Sertraline Hcl	174	43
Prednisone	Prednisone	170	33
Losartan Potassium	Losartan Potassium	126	26
Gabapentin	Gabapentin	120	21
Amlodipine Besylate	Amlodipine Besylate	113	35
Clopidogrel	Clopidogrel Bisulfate	113	31
Metoprolol Tartrate	Metoprolol Tartrate	111	40
Potassium Chloride	Potassium Chloride	111	35
Metoprolol Succinate	Metoprolol Succinate	109	26
Tamsulosin Hcl	Tamsulosin Hcl	100	30
Donepezil Hcl	Donepezil Hcl	96	23
Mirtazapine	Mirtazapine	96	34
Pantoprazole Sodium	Pantoprazole Sodium	96	42
Ondansetron Odt	Ondansetron	95	58
Memantine Hcl	Memantine Hcl	89	17
Quetiapine Fumarate	Quetiapine Fumarate	89	19
Allopurinol	Allopurinol	84	24
Lorazepam	Lorazepam	84	14
Omeprazole	Omeprazole	80	31
Escitalopram Oxalate	Escitalopram Oxalate	71	17
Carvedilol	Carvedilol	70	19
Tramadol Hcl	Tramadol Hcl	67	20
Metformin Hcl	Metformin Hcl	66	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	64	11
Citalopram Hbr	Citalopram Hydrobromide	61	14
Levetiracetam	Levetiracetam	61	11
Hydralazine Hcl	Hydralazine Hcl	60	suppressed
Methocarbamol	Methocarbamol	60	17
Albuterol Sulfate	Albuterol Sulfate	57	18
Duloxetine Hcl	Duloxetine Hcl	54	16
Risperidone	Risperidone	54	13
Spironolactone	Spironolactone	54	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	14
Divalproex Sodium	Divalproex Sodium	51	13
Ketoconazole	Ketoconazole	51	23
Fluticasone Propionate	Fluticasone Propionate	50	17
Triamcinolone Acetonide	Triamcinolone Acetonide	50	18
Xarelto	Rivaroxaban	49	suppressed
Morphine Sulfate	Morphine Sulfate	48	17
Lisinopril	Lisinopril	44	23
Oxycodone Hcl	Oxycodone Hcl	40	12
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	14
Albuterol Sulfate Hfa	Albuterol Sulfate	38	24
Galantamine Hbr	Galantamine Hbr	38	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	20
Hydroxyzine Hcl	Hydroxyzine Hcl	36	14
Oxcarbazepine	Oxcarbazepine	36	suppressed
Fentanyl	Fentanyl	35	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	35	14
Azithromycin	Azithromycin	34	24
Buspirone Hcl	Buspirone Hcl	33	suppressed
Ceftriaxone	Ceftriaxone Sodium	33	19
Nitroglycerin	Nitroglycerin	32	27
Latanoprost	Latanoprost	31	suppressed
Olanzapine	Olanzapine	31	suppressed
Santyl	Collagenase Clostridium Hist.	29	12
Verapamil Sr	Verapamil Hcl	28	suppressed
Alogliptin	Alogliptin Benzoate	27	suppressed
Amoxicillin	Amoxicillin	25	18
Klayesta	Nystatin	25	18
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	24	suppressed
Alprazolam	Alprazolam	23	suppressed
Budesonide	Budesonide	23	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	18
Cephalexin	Cephalexin	22	16
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Kerendia	Finerenone	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	11
Clonazepam	Clonazepam	20	suppressed
Finasteride	Finasteride	20	suppressed
Topiramate	Topiramate	20	suppressed
Diltiazem Hcl	Diltiazem Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Cefdinir	Cefdinir	18	13
Farxiga	Dapagliflozin Propanediol	18	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	18	11
Hydrochlorothiazide	Hydrochlorothiazide	18	suppressed
Lorazepam Intensol	Lorazepam	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Novolog	Insulin Aspart	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Sucralfate	Sucralfate	17	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	14
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	suppressed
Lactulose	Lactulose	16	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	16	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	15	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Lidocaine Hcl	Lidocaine Hcl	15	11
Midodrine Hcl	Midodrine Hcl	15	suppressed
Nystatin	Nystatin	15	11
Ondansetron Hcl	Ondansetron Hcl/Pf	15	13
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Travoprost	Travoprost	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Primidone	Primidone	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error